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Angiotensin H receptor-mediated proliferation of cultured human fetal
mesangial cells. Accumulating evidence suggests that angiotensin II
(Ang II) may play an important role in renal growth and glomerular
development. During nephrogenesis, a complex relationship between
the capillary and renal mesangium develops. Since the mesangial cell is
a centrally-located pericyte with contractile, endocrine, and immune
modulating functions, it may play a unique role in maintaining normal
glomerular function. Therefore, we examined whether Ang II affects
proliferation of human fetal mesangial cells in vitro and compared these
findings to mesangial cells isolated from adult kidney. In these primary
isolates, we studied the relationship between Ang II receptors and the
mitogenic activity of angiotensin. Scatchard analysis of the binding of
'251[Sar' ,11e8]Ang II to subconfluent cultured human fetal mesangial
cells revealed the presence of one class of binding sites with a Kd of
1.25 nM and a Bmax of70 fmol/I x iO cells. Ang II receptors on adult
mesangial cells had similar binding kinetics with a Kd of 1.6 n and
Bm of 65 fmol/105 cells in subconfluent culture. In subconfluent
culture of fetal mesangial cells, Ang II increased [3H]thymidine incor-
poration by 130% (P < 0.005). In subconfiuent culture of adult mesan-
gial cells, Ang II increased [3H]thymidine incorporation by only 35%
(P < 0.05). In confluent culture of fetal mesangial cells, Ang II receptor
number and mitogenic response were reduced. The Ang II antagonist
[Sar',11e8]Ang II (1 LM) inhibited the mitogenic response of fetal
mesangial cells to Ang II. Ang II increased fetal mesangial cell number
by 25% (after 4 days) in serum-free medium supplemented with insulin
or supplemented with insulin and 1% Nutridoma (P < 0.005). Thus, Ang
II is mitogenic for fetal mesangial cells but, in contrast, Ang II is only
weakly mitogenic for adult mesangial cells. These results are consistent
with a role for Ang II in glomerular development as well as in disease
states in which there is a change from the adult to the fetal phenotype.
The vasoactive octapeptide angiotensin II (Ang II) is an
important hormone in the maintenance of circulatory homeo-
stasis. Its numerous biological actions include vasoconstriction,
regulation of mineralocorticoid secretion, and regulation of
sodium and water intake and excretion [1]. In addition, recent
evidence suggests a potential role for the renin-angiotensin
system in cardiovascular development [2, 3]. The possibility
that Ang II may affect cell replication was first suggested by
Kharairallah, Robertson and Davila [41 when they demon-
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strated increased DNA content in atria, ventricles, adrenal
cortex and medulla of rats following an intravenous infusion of
Ang II. Since those original reports, unique receptors for Ang II
have been described in skeletal muscle and connective tissue of
the rodent fetus and primate fetus, and Ang II has been shown
to stimulate cell growth as well as the expression of platelet-
derived growth factor (PDGF) and growth-related oncogenes in
cultured smooth muscle cells [3, 5, 6]. The marked expression
of angiotensinogen, renin, Ang II converting enzyme and Ang II
receptors during the development of the fetal kidney and renal
vasculature suggests that the renin-angiotensin system may be
instrumental in nephrogenesis as well [7—9]. To investigate the
potential role of Ang II in promoting renal mesangial cell
proliferation, Ang II receptors were characterized on cultured
human fetal and adult mesangial cells, and the effect of Ang II
to stimulate cell proliferation and DNA synthesis was analyzed.
Methods
Tissue culture: Human fetal and adult mesangial cells
isolation
Human fetal kidney tissue was obtained, in accordance with
N.I.H. guidelines, from therapeutic abortions performed at 15
weeks gestational age. Normal adult human kidney tissue was
obtained as surgical waste from kidneys removed for renal
carcinoma. Kidney glomeruli were isolated according to stan-
dard techniques as reviewed by Striker et a! [10, 11]. Briefly,
whole fetal kidney or cortex from adult kidney was minced into
1 mm fragments and passed through a graded series of metal
sieves. The resulting material, containing > 95%glomeruli and
<5% tubules by microscopic examination, was incubated for
30 minutes with collagenase (Sigma type IV, Sigma Chemical
Co., St. Louis, Missouri, USA) at 37°C. After centrifugation,
pelleted glomeruli were resuspended in Dulbecco's Modified
Eagles Medium (DMEM, Biofluids, Rockville, Maryland, USA)
mixed 1: 1 with Ham's F12 (Biofluids) containing 4.5 g/liter
glucose, 20% heat inactivated fetal calf serum (Gibco, Grand
Island, New York, USA), 2 mrvi glutamine, 100 U/mI penicillin,
100 p.g/ml streptomycin and 8 M insulin. Fetal mesangial cells
were seeded in 100 cm2 tissue culture plates (Falcon 3003,
Lincoln Park, New York, USA) and studied between passages
4 and 11. Adult mesangial cells were studied between passages
4 and 7.
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Fig. 1. Human fetal mesangial cells
express abundant actin containing
microfilaments, recognized by Bodipy-
phallacidin under epifluorescence.
Mesangial cells from adult and fetus had a similar, character-
istic phenotype manifested by polygonal shape, positive stain-
ing for F-actin using Bodipy-phallacidin (Molecular Probes,
Eugene, Oregon, USA) [12] (Fig. 1) and, in confluent culture,
the formation of ridges composed of multiple layers of cells
surrounding regions of monolayers. Both fetal and adult mesan-
gial cells lacked the close cell-cell contact typical of endothelial
and epithelial cells. Mesangial cells were also characterized by
immunofluorescence with the following primary antibodies:
anti-human von Willebrand's factor (Dakopatts, Copenhagen,
Denmark), anti-human vimentin, anti-smooth muscle myosin
(Zymed, San Francisco, California, USA), anti-collagen type
IV, and anti-laminin [13]. Mesangial cells did not stain with the
antibody to von Willebrand's factor (positive control: human
umbilical vein endothelial cells) but stained positively for intra-
cellular microfilaments detected by the anti-vimentin and anti-
myosin antibodies. Both fetal and adult mesangial cells consti-
tutively expressed matrix proteins which stained with the
antibodies to collagen type IV, fibronectin and laminin.
Measurement of Ang II receptors
'251[Sar1 ,Ile8]Ang II was prepared by modified chloramine-T
radioiodination and purified by HPLC using a C-18 column with
acetonitrile/0.l M ammonium bicarbonate (15:85) buffer pH 8.0.
The specific activity of the tracer ranged from 1500 to 1800
as determined by radioreceptor assay using rat adrenal
gland capsular membranes. Maximum binding activity of the
tracer to adrenal membranes was 50% to 70% [141.
For binding analysis, cells were cultured at densities which,
at the time of the experiments, ranged from 2.5 x 102 to I x
cells/well in 24 well (16 mm diameter, Gibco) tissue culture
plates. After removal of the culture medium, cells were washed
twice with 1 ml phosphate buffered saline (PBS), pH 7.4. Cells
were then incubated with 100,000 cpm of '251[Sar1,11e8]Ang II
(0.25 nM) either in the presence of increasing concentrations of
unlabeled Ang II or its analogues (Sigma). Cells were incubated
in 0.5 ml medium 199 (Gibco), containing 0.1% bovine serum
albumin and EDTA 0.5 m for one hour at 37°C in a humidified
incubator under 95% air and 5% CO2. Five minutes prior to the
end of the incubation, cells were detached with 0.01% trypsin
and the bound radioactivity was separated by filtration through
OF/C glass fiber filters. Cells were washed twice with 2 ml of
PBS using a Brandell cell harvester attached to a 24-well plate
adapter. Radioactivity on the filters was analyzed in a Beckman
5500 gamma counter with a counting efficiency of 70% for [12511.
Preliminary experiments demonstrated that detaching the cells
from the wells by the addition of trypsin five minutes prior to
filtration did not affect binding when compared to results
obtained by conventional methods (washing twice with cold
PBS and recovery of the radioactivity by NaOH hydrolysis).
Specific binding was calculated from triplicate samples ob-
tained by subtracting the bound nonspecific radioactivity from
the bound total radioactivity. Nonspecific binding measured in
the presence of excess unlabeled Ang II (1 .tM) was less than
10% of the total binding in all experiments. Ang II binding
experiments were repeated at least three times. Binding affinity
and receptor concentration were calculated by computerized
analysis as described by Munson and Rodbard [15]. Since
Scatchard analysis showed no changes in binding affinity be-
tween confluent and non confluent cultures, in most experi-
ments binding was estimated from the binding data using a
single concentration of Ang 11(1.2 nM). Using this procedure,
changes in binding were proportionate to the changes in recep-
tor concentration. Cell counts were performed in six individual
wells in each experiment using a cell counter (Coulter Electron-
ics Boston, Lanham, Maryland, USA).
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Fig. 2. Displacement of'251[Sar',11e8]Ang Ii binding
from fetal mesangial cells by different Ang ii
analogs. Symbols are: (Lx) [Sar',Ile9Ang II; (•)
[Sar']Ang II; (0) Ang II; (D) Ang III; (A) Ang 1.
The inset represents a Scatchard analysis of binding
data at equilibrium, generated by the computer
assisted program LIGAND [15) and reveals a single
class of binding sites in human fetal mesangial cells.
Effect of Ang II on cell number and DNA synthesis
Fetal mesangial cells were plated in 24-well tissue culture
plates at either high density (2 x iO cells/cm2) or low density
(6 x io cells/cm2) under one of the following four conditions:
(1.) serum-free DMEM-F12 without supplementation (SF); (2.)
serum-free DMEM-Fl2 supplemented with insulin (SF + I); (3.)
serum-free DMEM-F12 supplemented with insulin and 1%
Nutridoma-HU (Boehnnger Mannheim, Indianapolis, Indiana,
USA) (SF + I + N); or (4.) DMEM-F12 supplemented with 20%
fetal calf serum. Nutridoma-HU is a defined culture medium
supplement which includes 5 j.g/ml of insulin and transferrin, 5
ng/ml selenium and 40 j.g/ml human serum albumin. With the
exception of insulin this medium supplement does not contain
any hormones including steroids or growth factors. Previous
studies have shown that serum is required for mesangial cell
growth [16]. In these experiments we demonstrated that sup-
plementation of DMEM-F12 with insulin and 1% Nutridoma
allowed growth of mesangial cells without serum. Twelve hours
alter plating cells in the 24 well plates, Ang 11(10 or 100 nM) or
vehicle was added to the medium. Ang II or vehicle-containing
medium was changed daily and cells were counted after four
days of treatment in a cell counter (Coulter Electronics).
The effect of Ang II on DNA synthesis was measured by
[3H]thymidine (DuPont-New England Nuclear, Boston, Massa-
chusetts, USA) incorporation. Cells plated at various densities
were made quiescent by placing them in serum-free medium
with or without insulin for 48 hours. Cells were then incubated
under the various culture conditions (outlined above) with 100
flM Ang II for 2 to 18 hours. After exposure to Ang II, 1 itCi/ml
of [3H]thymidine was added to each well and incubation was
continued for an additional five hours at 37°C. Wells were
washed twice with cold PBS and then three times with ice-cold
5% trichioroacetic acid to precipitate proteins and nucleic acids
and to remove unincorporated [3H]thymidine. The precipitate
was solubilized by the addition of 1 ml of 0.25 M NaOH and
0.1% sodium dodecyl sulfate (SDS) and incubated at 37°C for 30
minutes. One ml aliquots were neutralized, added to 10 ml of
scintillation fluid and counted in a liquid scintillation counter
(60% efficiency for [3H}). To account for differences in baseline
[3H] incorporation between assays, results (cpm/well) were
expressed as the percentage increase over control values.
Degradation of Ang II was measured by rebinding in a
radioreceptor assay, as the quantity of the peptide remaining in
the medium after incubation with the cells. In serum-free
medium, 90% of the peptide remained after 12 hours, however,
in medium supplemented with 20% fetal calf serum, only 5% of
the peptide was present after four hours and the peptide was
undetectable after 12 hours.
Statistical analysis
Results are expressed as the mean SEM. Significant changes
were determined by a one-way analysis of variance followed by
post hoc analysis with the Newman-Keuls test. To compare
changes within groups, results were analyzed using Student's
paired t-test.
Results
Ang II receptor binding
Specific binding of '251[Sar' ,11e8]Ang II to human fetal and
adult mesangial cells increased in a linear fashion up to 60
minutes of incubation and remained at a plateau from one to
three hours. As shown in Figure 2 inset, Scatchard analysis of
binding data at equilibrium revealed a single class of binding
sites on subconfluent fetal mesangial cells with a Kd of 1.25 nM
and a Bmax of 70 fmol/105 cells. Ang II receptors on adult
mesangial cells had similar binding kinetics with a Kd of 1.6 flM
and Bmax of 65 fmol/105 cells in subconfluent culture (Scatchard
analysis not shown). The specificity of the binding was demon-
strated by the ability of Ang II analogues to displace the binding
of '251[Sar' ,11e8]Ang II from mesangial cells (fetal cells shown in
Fig. 2). The superagonist [Sar']Ang II and the antagonist
[Sar'-Ile8JAng II were more potent than Ang II with IC50 values
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Fig. 3. Relationship between cell growth and Ang II receptor number
in human fetal mesangial cells grown in medium supplemented with
20% fetal calf serum. Symbols are: (El) all receptors; (•) cell number.
As cells approached confluence between days 5 and 6, Ang II receptor
number decreased. Each point represents the mean SEM of 18
observations for receptor number and mean SEM for 20 observations
for cell number.
of 0.7 flM, 0.3 n and 2 flM, respectively. Ang I and Ang III
were less potent with an IC50 of 300 flM and 50 flM, respectively.
To determine the relationship between cell growth and recep-
tor number, human fetal mesangial cells were plated at a density
of 2 x io cells/cm2 and Ang II binding and cell number were
analyzed each day for seven days. As shown in Figure 3, in the
presence of fetal calf serum, cell number increased rapidly
before reaching confluence between days 5 and 6. Twenty-four
hours after plating, Ang II receptor number was 68 3 fmol/105
cells and remained at a similar number during the period of
logarithmic growth (3 additional days). At confluence (5.5 X l0
cells/cm2), Ang II receptor number decreased again to 45 3
fmolIlO5 cells. Similarly, when cells were plated at different
densities (2.5, 5, 10, 25, 50, or 100 x io cells/cm2), Ang II
binding per cell was inversely correlated with cell density (data
not shown).
Effect of Ang II on cell number
To determine the ability of Ang II to induce mitogenesis in
mesangial cells, cell number was determined after incubating
cells with 10 or 100 nM Ang II for four days under different
culture conditions. When fetal mesangial cells were plated at
high density (2 x l0 cells/cm2) in SF or SF + I, Ang II had no
effect on cell number (data not shown). At the same cell density
in SF + I + N, however, Ang II caused a significant increase in
cell number from 24,745 1,450 to 36,910 1,324 cells/cm2
with 10 nM Ang II (P < 0.005) and from 23,670 1,200 to
35,500 2,950 cells/cm2 with 100 n Ang II (P < 0.005). To
assess maximal mitogenic response, mesangial cells were plated
in medium supplemented with 20% fetal calf serum and cell
number increased from 24,567 1,234 to 130,000 2,340
cells/cm2. Under these conditions, addition of 100 nsi Ang II did
not significantly increase cell number when compared to the
effects of fetal calf serum alone (128,560 3,000 cells cm2).
When the cells were plated at lower density (6 X io
cells/cm2), the mitogenic effect of Ang II was evident both when
cells were plated in SF + I or SF + I + N. As shown in Figure
4, 100 flM Ang II increased cell number from 6,900 250 to
10,780 350 cells/cm2 in SF + I (P < 0.05) and from 8,700
Fig. 4. Mitogenic effect of Ang II on fetal mesangial cell number.
Symbols are: (0) control; () +Ang II. Cells were plated at low density(6 X l0 cells/cm2) in serum-free medium supplemented with insulin
(SF + I) or serum-free medium supplemented with insulin and Nutri-
doma (SF + I + N). Culture medium containing 100 nM Ang II or
vehicle control was changed daily. After four days, cells were detached
with trypsin and counted as described in Methods. The asterisk (*)
represents a significance of P < 0.005 when Ang Il-treated cells were
compared to control cells. The cross (t) represents a P < 0.005 when
control cells in SF + I + N medium were compared to control cells in
SF + I medium. The bars represent the mean SEM for 24 observa-
tions.
230 to 12,870 550 cells/cm2 in SF + I + N (P <0.05). The
addition of Nutridoma alone to SF + I produced a small but
significant increase in control cell number from 6,900 250 to
8,700 230 cells/cm2 (P < 0.05). Similar to the results at higher
cell density, no additional mitogenic effect of Ang II could be
observed in the presence of 20% fetal calf serum (89,456
1,100 vs. 91,456 1,300 cells/cm2).
DNA synthesis
Consistent with the effects of Ang II on cell number, expo-
sure of the quiescent cells to Ang II for 18 hours in SF + I or
SF + I + N resulted in significant stimulation of thymidine
incorporation. As shown in Figure 5, the effect of Ang II on
thymidine incorporation was dose-dependent with an EC50 of 6
n and a maximum stimulatory activity of 300 ntvt.
In SF + I medium, 10 nst Ang II increased thymidine
incorporation by 53 4% (P < 0.005) and 100 nM Ang II
increased thymidine incorporation by 79 5% (P < 0.005). In
contrast, no significant effect of Ang II was observed in SF
medium (2,034 265 control; 2,100 245 with 10 nM Ang II;
and 2,428 802 with 100 flM Ang II cpm/well). In SF + I + N,
Ang II had a slightly higher stimulatory effect (120 7% and
150 8% with 10 and 100 nr.t Ang II respectively; P < 0.005).
The stimulatory effect of Ang II on [3H]thymidine incorporation
was significantly less than the 10-fold increase induced by
serum-containing medium. Since significant degradation of Ang
II occurred in the presence of fetal calf serum, an additional
experiment was performed using a supraphysiological concen-
tration of Ang 11(100 JLM). Eighteen hours after the addition of
Ang II to serum-containing medium, there was no significant
increase in [3H]thymidine incorporation (23,456 2,456 vs.
21,345 2,340 cpm/well.)
The time course of the mitogenic response of mesangial cells
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Fig. 5. Dose-response curve for the effect of Ang 11 on [methyl-
3H]thymidine incorporation by human fetal mesangial cells. Quiescent
cells (5 x l0 cells/cm2) in serum-free, insulin, and Nutridoma supple-
mented medium (SF + I + N) were treated with increasing Ang II
concentrations for 18 hours. Cells were pulsed with 1 Ci/ml [methyl-
3H]thymidine for an additional five hours prior to harvest. Each point
represents the mean SEM of 6 observations.
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Fig. 6. Time course of the effect of 100 nM Ang II on [methyl-
3HJthymidine incorporation by human fetal mesangial cells. Symbols
are: (•) Ang II; (0) control. Cells were plated at 5 x i0 cells/cm2 and
made quiescent in serum.free medium for 48 hours. Ang II was then
added to the cell cultures in serum-free, insulin, and Nutridoma
supplemented medium (SF + I + N) for 2, 4, 8, 12 and 18 hours
followed by [methyl-3H]thymidine pulse for an additional five hours.
Each point represents the mean SEM of 12 observations.
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4 Fig. 7. The relationship between cell growth (number of days in
culture) and the ability of Ang II to stimulate [methyl-3H]thymidine
incorporation by human fetal mesangial cells. Symbols are: (0)100 nM;
(Lx) 100 nM Ang II + I /LM [Sar',Ileu8JAng II; (El) control. All cells
were plated at a density of 4 x l0 cells/cm2 in medium supplemented
with 20% fetal calf serum on day 0. On each subsequent day, a different
set of cells was made quiescent in serum-free medium supplemented
with insulin (SF+I) for 48 hours. After this period, the cells were
treated with 100 nM Ang II, I M [Sar',tle8]Ang II + 100 flM Ang II or
control vehicle in serum-free, insulin, and Nutridoma supplemented
medium (SF+I+N). After 18 hours, cells were pulsed with [methyl-
3H]thymidine as described in methods. The asterisk (*) represents P <
0.005 when 100 flM Ang H was compared with Ang II + antagonist or
control. The cross (t) represents (P < 0.05 when Ang II + antagonist
was compared with control. Each point represents the mean SEM of
18 observations.
antagonist [Sar' ,Ile8JAng II. As demonstrated in Figure 7, on
each day of culture, the increase in [3H]thymidine incorporation
induced by Ang II was completely inhibited by the Ang II
receptor antagonist. The stimulatory effect of Ang II on thymi-
dine incorporation decreased with increasing confluence of the
culture. After 10 days in culture (data not shown), neither 10 flM
nor 100 flM Ang II caused a significant increase in thymidine
incorporation in human fetal mesangial cells.
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Effect of Ang II on cell growth in adult mesangial cells
In contrast to the effect on fetal mesangial cells, Ang II
18 induced only a weak mitogenic response in adult mesangial cells
and only under certain culture conditions. Adult cells between
passages 3 and 5 were plated at a density of 6>< i0 cells/cm2 in
SF + I + N for five days. Daily addition of Ang 11(100 nM) to
the medium for five days increased cell number 25 4% (P <
0.05). In addition, subconfiuent cells (4 x iO cells/cm2) were
synchronized by serum starvation for 48 hours, and then
stimulated with vehicle or 100 flM Ang II for 18 hours in SF +
I + N medium. Under these experimental conditions, [3H]thy-
midine incorporation increased significantly by 35 6% (P <
0.05) but remained much less than that observed for fetal
mesangial cells.to 100 nM Ang II in SF + I + N is shown in Figure 6. The
earliest significant response was observed 12 hours after the
addition of Ang II. To test the specificity of the Ang II The possibility that Ang II might stimulate mesangial mito-
mitogenic effect, cells plated in culture for one to six days were genesis during renal development has been an attractive hy-
treated for 18 hours with either 100 flM Ang II alone or in pothesis because all components of the renin-angiotensin sys-
combination with a 10-fold excess of the Ang II receptor tern are expressed in renal vasculature during development.
Discussion
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Unfortunately, this hypothesis has been difficult to substanti-
ate. The present study provides the first clear demonstration for
a mitogenic effect of Ang II in human fetal mesangial cells in
vitro. Addition of Ang II to fetal mesangial cell culture in-
creased DNA synthesis as well as cell number in a time-
dependent and dose-dependent manner and the mitogenic effect
of Ang II was prevented by Ang II receptor antagonists.
Several previous studies have suggested a potential effect of
Ang II on adult mesangial cell growth [17—22]. Attempts to
explore the direct effect of Ang lion mesangial cell proliferation
in vitro, however, have rendered conflicting results. Several
important variables may explain these differences including
specific cell culture conditions, age of the tissue from which
cells are isolated, and species variations in the cellular response
to angiotensin. The majority of reports have suggested that Ang
II has no mitogenic effect on mesangial cells [17—20]. In the
present study, we detected only a weak mitogenic response in
adult cells under specific culture conditions. In contrast, fetal
mesangial cells were much more responsive to the mitogenic
effects of Ang II despite the presence of similar Ang II receptor
number and affinity.
Although the mitogenic effect of Ang II on fetal mesangial
cells was prominent, a number of culture conditions profoundly
affected Ang II receptor number and mesangial response.
During logarithmic cellular growth, Ang II markedly stimulated
fetal mesangial mitogenesis, but in confluent cultures the effect
of Ang II was less prominent. Furthermore, the culture medium
strongly influenced the magnitude of the effects of Ang II on
thymidine incorporation and cell proliferation. For example,
Nutridoma supplementation of medium potentiated the mito-
genic effect of Ang II. Previous studies have suggested that
mesangial cells cannot grow in unsupplemented SF medium,
but Nutridoma was an effective supplement to SF medium and
allowed growth of the cells in culture for several days. Further
studies are needed to determine which component of Nutri-
doma is responsible for its permissive effect on mesangial cell
growth.
In the present study, the mitogenic effect of Ang II required
other factors such as insulin or Nutridoma. Similar co-factor
dependence by Ang Ii has been reported previously in other
cells. For example, Ang II potentiates the proliferative effects
of EGF on renal tubular cells [23] and of PDGF on vascular
smooth muscle cells [3]. This is consistent with the suggestion
that Ang II acts as a competence factor [16, 24, 25]. In the
present study, there was no additional mitogenic effect of Ang
II in the presence of 20% fetal calf serum, even when micro-
molar concentrations were added to medium. A number of
factors may explain this finding including peptide degradation,
the masking of a mitogenic effect by serum-stimulated maximal
growth, or the potential interaction of Ang II with other factors
present in serum. Thus, the potential effect of Ang II as a
mitogenic agent in vivo remains to be determined.
Factors other than culture conditions may also explain the
variable results for Ang II stimulation of mitogenesis reported
in the literature. For example, in the present study, the prolif-
erative action of Ang II was much more apparent in fetal human
mesangial cells when compared to cells isolated from adults.
Most previous studies which have failed to find a mitogenic
effect of Ang II have been performed in cells isolated from adult
tissues under different culture conditions. In addition, the
response to Ang II may well be different in human cells when
compared to those of the rat. The ontogeny of angiotensinogen
and renin gene expression demonstrates marked species differ-
ences between the rat, mouse and sheep [6—8] and the biosyn-
thesis and secretion of renin also differs in human and mouse
tissues [7]. Thus, the response to Ang II may be dependent
upon the age and state of differentiation of the cells as well as
the species from which the cells were isolated.
Alterations in Ang II receptors may contribute to the variable
response of mesangial cells to Ang II. The number of Ang II
receptors in mesangial cells markedly decreased when cultures
reached confluence, suggesting that receptor expression is
inversely proportional to the growth potential of the cells. This
is similar to the findings in the fetus, where abundant Ang II
receptors are present in rapidly growing tissues, such as skel-
etal muscle and skin, and then decrease in number after birth
and become undetectable when growth is completed [5]. The
reason for this decrease in receptor number is unclear, but may
be the result of other modulating factors secreted into the
medium. Since confluent cells exhibited a decreased response
not only to Ang II but also to serum and growth factors, it is
possible that down-regulation of growth-related receptors is a
more general phenomenon associated with contact inhibition. It
remains to be determined whether the decrease in Ang II
receptor number observed during confluence is responsible for
the parallel decrease in mitogenic activity of the peptide.
The fact that the mitogenic effect of Ang II is more significant
during periods of rapid cell growth suggests that Ang II may
have a particularly important role during renal development and
in the pathogenesis of glomerular disease. In this regard, it has
been recently reported that converting enzyme inhibitors are
more beneficial in preventing glomerular sclerosis when admin-
istered during the periods in which the kidneys are undergoing
hypertrophy [26]. Similarly, converting enzyme inhibition pre-
vents the development of myointimal proliferation after vascu-
lar injury [27]. Infants and young animals have more Ang II
receptors in vascular tissue and brain compared to adults,
raising the possibility that developing tissues are particularly
susceptible to the mitogenic effects of Ang II [28]. Furthermore,
infants have higher plasma renin levels compared to adults [29],
suggesting that the renin-angiotensin-aldosterone axis is acti-
vated and may play a role in development.
The mitogenic effect of Ang II in mesangial cells observed in
the present study is clearly different from the well-documented
effects of the peptide in cultured rat vascular smooth muscle
cells, where it is known to cause hypertrophy, but not cell
division [6]. But, angiotensin has been found to cause prolifer-
ation of vascular tissue in species other than the rat; Ang II
stimulates mitogenesis of human smooth muscle cells [30].
These data suggest that the mitogenic effect of angiotensin may
be dependent upon species and culture conditions. Further-
more, tissue specificity of the mitogenic response may reflect
subtle differences in the Ang II receptor type in various tissues
or different species. Pharmacological evidence based on the
effects of Ang II antagonists suggests the existence of receptor
subtypes in different tissues [31, 32]. Studies in the rat have
shown that mesangial cells have higher affinity for Ang III than
smooth muscle cells [31, 32]. On the other hand, mesangial cells
are similar to smooth muscle cells in embryologic origin,
histology and functional properties and the relative potencies of
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Ang II analogs shown in the present study are similar to those
described for smooth muscle. Although there are a number of
similarities between mesangial and vascular smooth muscle
cells, the observed qualitative differences in the response of
mesangial and smooth muscle cells to Ang II may reflect
fundamental differences in angiotensin receptor type, tissue-
specific response, or culture conditions.
Further studies are needed to determine the mechanism by
which Ang II stimulates DNA synthesis and cell division. Ang
II may modulate growth directly or through the expression of
other growth factors or proto-oncogenes. In cultured vascular
smooth muscle cells, Ang II stimulates the expression of PDGF
and the growth-related proto-oncogene c-fos [3, 6]. In addition,
since the Ang II mitogenic effect requires the presence of
insulin it is possible that the effects of Ang II are modulated by
an interaction with insulin and the IGF-I receptor. Thus, the
supraphysiologic levels of insulin used in this study may acti-
vate IGF-I receptors and potentiate the growth promoting
effects of Ang II. Furthermore, Ang II and IGF-I have recipro-
cal positive effects on the regulation of their membrane bound
receptors [33] in cultured bovine adrenocortical cells, suggest-
ing that positive trophic interactions between both hormones
may occur. In adult mesangial cells, as well as in vascular
smooth muscle cells, adrenal glomerulosa cells, hepatocytes
and fetal fibroblasts, the binding of Ang II to its cell-surface
receptor initiates a transmembrane signal linked to the mobili-
zation of intracellular calcium, inositol phosphate and diacyl-
glycerol formation [34—40]. Thus, it is likely that the mitogenic
effect of the peptide is linked to a calcium phospholipid signal-
ling mechanism and an interaction between a number of growth
stimulating receptors may interact upon a common signal
transduction pathway.
In conclusion, the present study demonstrates a mitogenic
effect of Ang II in fetal human mesangial cells in the presence of
insulin. Under these culture conditions, fetal mesangial cells
have functional Ang II receptors. The mitogenic response is
specific for Ang II and can be blocked by the Ang II receptor
antagonist [Sar',11e8]Ang II. The Ang II effect is more signifi-
cant in mesangial cells during the period of logarithmic growth,
while decreased Ang II responsiveness parallels the decrease in
Ang II receptor number. Therefore, Ang II may act as a
competence-like mitogen with an important role in human fetal
kidney development and in the proliferative response of mesan-
gial cells to injury.
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